956 related articles for article (PubMed ID: 15854512)
1. [Effects of teriparatide and alendronate on bone mineral density of osteoporotic rats].
Li M; Jiao J; Meng XW; Xing XP; Xia WB; Zhou XY; Liu HC; Jiang Y; Wang O; Hu YY; Zhan ZW
Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(5):335-8. PubMed ID: 15854512
[TBL] [Abstract][Full Text] [Related]
2. [Skeletal biomechanical properties improvement in ovariectomized osteoporotic rats of teriparatide was retarded by alendronate].
Li M; Jiao J; Meng XW; Zhou XY; Xing XP; Xia WB; Wang O; Jiang Y; Liu HC; Hu YY
Zhonghua Nei Ke Za Zhi; 2006 Feb; 45(2):104-7. PubMed ID: 16624115
[TBL] [Abstract][Full Text] [Related]
3. [Effects of Dioscorea septemloba on bone metabolism in ovariectomized rats].
Xing GS; Lou JS; Wang ZB; Yu SL; Wang Y; Sheng L
Zhongguo Zhong Yao Za Zhi; 2007 Sep; 32(18):1909-13. PubMed ID: 18051905
[TBL] [Abstract][Full Text] [Related]
4. [Changes of urinary deoxypyridinoline crosslink/creatinine in rats after ovariectomy and anti-osteoporotic intervention].
Hu YY; Xia WB; Liu HC; Meng XW; Zhou XY; Xing XP
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Jun; 25(3):271-4. PubMed ID: 12905738
[TBL] [Abstract][Full Text] [Related]
5. Skeletal effects of parathyroid hormone infusion in ovariectomized rats with or without estrogen repletion.
Shen V; Birchman R; Wu DD; Lindsay R
J Bone Miner Res; 2000 Apr; 15(4):740-6. PubMed ID: 10780865
[TBL] [Abstract][Full Text] [Related]
6. [Alendronate prevents steroid-induced osteoporosis in patients with rheumatic diseases].
Wang QH; Wu HX; Huang YL; Xue J; Yang XY; Zhu L; Wen LH
Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(27):1888-91. PubMed ID: 19040000
[TBL] [Abstract][Full Text] [Related]
7. [Evaluation of bone structure and quality of ovariectomized rats by microcrack].
Dai RC; Liao EY; Yang C
Hunan Yi Ke Da Xue Xue Bao; 2003 Dec; 28(6):591-6. PubMed ID: 15804068
[TBL] [Abstract][Full Text] [Related]
8. [Effects of 1 alpha(OH)D3 on trabecular and cortical bone in ovariectomized rats].
Xia W; Meng X; Xing X; Hu Y; Liu H; Zhou X; Qiu G; Yang X; Shen V; Wu D; Dempster D; Lindsay R
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2000 Dec; 22(6):543-7. PubMed ID: 12903400
[TBL] [Abstract][Full Text] [Related]
9. Correlations between biochemical markers of bone turnover and bone density responses in patients with glucocorticoid-induced osteoporosis treated with teriparatide or alendronate.
Burshell AL; Möricke R; Correa-Rotter R; Chen P; Warner MR; Dalsky GP; Taylor KA; Krege JH
Bone; 2010 Apr; 46(4):935-9. PubMed ID: 20060081
[TBL] [Abstract][Full Text] [Related]
10. A synergistic bone sparing effect of curcumin and alendronate in ovariectomized rat.
Cho DC; Kim KT; Jeon Y; Sung JK
Acta Neurochir (Wien); 2012 Dec; 154(12):2215-23. PubMed ID: 23053289
[TBL] [Abstract][Full Text] [Related]
11. Maintenance of increased bone mass after recombinant human parathyroid hormone (1-84) with sequential zoledronate treatment in ovariectomized rats.
Rhee Y; Won YY; Baek MH; Lim SK
J Bone Miner Res; 2004 Jun; 19(6):931-7. PubMed ID: 15125792
[TBL] [Abstract][Full Text] [Related]
12. [Effect of cyclooxygenase-2 on bone loss in ovariectomized rats].
Guo Y; Zhang CY; Tian Y; DI JM; Qin S
Zhonghua Fu Chan Ke Za Zhi; 2012 Jun; 47(6):458-62. PubMed ID: 22932114
[TBL] [Abstract][Full Text] [Related]
13. Baseline glucocorticoid dose and bone mineral density response with teriparatide or alendronate therapy in patients with glucocorticoid-induced osteoporosis.
Devogelaer JP; Adler RA; Recknor C; See K; Warner MR; Wong M; Krohn K
J Rheumatol; 2010 Jan; 37(1):141-8. PubMed ID: 19918047
[TBL] [Abstract][Full Text] [Related]
14. Response rate of bone mineral density to teriparatide in postmenopausal women with osteoporosis.
Gallagher JC; Rosen CJ; Chen P; Misurski DA; Marcus R
Bone; 2006 Dec; 39(6):1268-75. PubMed ID: 16884968
[TBL] [Abstract][Full Text] [Related]
15. [Effects of Dioscorea septemloba on the biomechanical and bone histomorphometric parameters of femur in the ovariectomized rats].
Xing GS; Lou JS; Yu SL; Wang ZB; Shi YJ
Zhong Yao Cai; 2008 Feb; 31(2):272-6. PubMed ID: 18619278
[TBL] [Abstract][Full Text] [Related]
16. Long-term minodronic acid (ONO-5920/YM529) treatment suppresses increased bone turnover, plus prevents reduction in bone mass and bone strength in ovariectomized rats with established osteopenia.
Tanaka M; Mori H; Kayasuga R; Ochi Y; Kawada N; Yamada H; Kishikawa K
Bone; 2008 Nov; 43(5):894-900. PubMed ID: 18687415
[TBL] [Abstract][Full Text] [Related]
17. Long-term skeletal effects of recombinant human growth hormone (rhGH) alone and rhGH combined with alendronate in GH-deficient adults: a seven-year follow-up study.
Biermasz NR; Hamdy NA; Pereira AM; Romijn JA; Roelfsema F
Clin Endocrinol (Oxf); 2004 May; 60(5):568-75. PubMed ID: 15104559
[TBL] [Abstract][Full Text] [Related]
18. Effect of combined humanPTH(1-34) and calcitonin treatment in ovariectomized rats.
Washimi Y; Ito M; Morishima Y; Taguma K; Ojima Y; Uzawa T; Hori M
Bone; 2007 Nov; 41(5):786-93. PubMed ID: 17707708
[TBL] [Abstract][Full Text] [Related]
19. Alendronate influences bending force of femoral diaphysis after orchidectomy in rats.
Huuskonen J; Arnala I; Olkkonen H; Alhava E
Ann Chir Gynaecol; 2001; 90(2):109-14. PubMed ID: 11459259
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological treatment of osteopenia induced by gastrectomy or ovariectomy in young female rats.
Andersson N; Surve VV; Lehto-Axtelius D; Andersson K; Ryberg B; Ohlsson C; Håkanson R
Acta Orthop Scand; 2004 Apr; 75(2):201-9. PubMed ID: 15180236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
